Skip to main content
Caplight Logo









Reacta Healthcare

Reacta Healthcare

Private
DeesideHealthcare & Life Scienceshttps://reactahealthcare.com/

Last Round

Grant

Apr 27, 2022

Total Funding Raised

$1.54M

Company Overview

Reacta Healthcare is a life sciences company that develops and manufactures pharmaceutical-grade oral food challenge products for use in food allergy clinical trials.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

oral food challengeOFCfood allergy diagnosisclinical trial materialsallergy testingpharmaceutical manufacturingGMP certifiedcontract research organizationCROanalytical testingfood allergy researchdiagnostic mealsallergy challenge

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Reacta Healthcare Comparables

Compare Reacta Healthcare with similar companies based on industry and business-model similarity.

Reacta Healthcare comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Stallergenes Greer
53%
Thermo Fisher Scientific Inc.
51%
AllerGenis
48%

Reacta Healthcare Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantApr 27, 2022
VC RoundJul 14, 2021
VC RoundApr 21, 2020

Key People

Founding team and executive leadership

Simon Thelwall-Jones

Chief Financial Officer

Executive Team

Rob Barker

COO

Executive Team

Reacta Healthcare Investors

Notable investors and investment history

Reacta Healthcare investors
InvestorRounds
Praetura VenturesVC Round
Innovate UKGrant
Perscitus LLPVC Round
Acceleris CapitalVC Round
Development Bank of WalesSeed, VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2026

    Monthly visitors increased 8908% to 6.6K.

  • Dec 4, 2025

    Monthly visitors increased 163% MoM.

Reacta Healthcare Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Reacta Healthcare Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Reacta Healthcare's valuation, stock price, and market status.

Firmographic Details

HeadquartersDeeside
Employee Range77
Year Founded2013
Last FundingApr 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?